REFERENCES
1. Hruby A, Manson JE, Qi L, et al. Determinants and consequences of obesity. Am J Public Health. 2016;106:1656-62.
2. World obesity. World obesity atlas 2023. Available from: https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023. [Last accessed on 7 Jul 2025].
3. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1:11-25.
4. in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. The Lancet. 2016;387:1377-96.
5. Khosravi-largani M, Nojomi M, Aghili R, et al. Evaluation of all types of metabolic bariatric surgery and its consequences: a systematic review and meta-analysis. OBES SURG. 2019;29:651-90.
6. Wharton S, Serodio KJ, Kuk JL, Sivapalan N, Craik A, Aarts M. Interest, views and perceived barriers to bariatric surgery in patients with morbid obesity. Clinical Obesity. 2016;6:154-60.
7. Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93:343-52.e2.
8. Zhang L, Tan WH, Chang R, Eagon JC. Perioperative risk and complications of revisional bariatric surgery compared to primary Roux-en-Y gastric bypass. Surg Endosc. 2015;29:1316-20.
9. Jirapinyo P, Hadefi A, Thompson CC, et al. American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity. Endoscopy. 2024;56:437-56.
10. Neylan CJ, Dempsey DT, Tewksbury CM, Williams NN, Dumon KR. Endoscopic treatments of obesity: a comprehensive review. Surg Obes Relat Dis. 2016;12:1108-15.
11. Bradley D, Magkos F, Klein S. Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology. 2012;143:897-912.
12. Phillips RJ, Powley TL. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol. 1996;271:R766-9.
13. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-30.
14. Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, et al. Endoscopic bariatric therapies. Gastrointest Endosc. 2015;81:1073-86.
15. Familiari P, Costamagna G, Bléro D, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc. 2011;74:1248-58.
16. Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis. 2012;8:296-303.
17. Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008;68:51-8.
18. Devière J, Valdes GO, Herrera LC, et al. Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc. 2008;22:589-98.
19. Feitoza AB, Gostout CJ, Rajan E, et al. Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plications. Gastrointest Endosc. 2003;57:868-76.
20. Menchaca HJ, Harris JL, Thompson SE, Mootoo M, Michalek VN, Buchwald H. Gastric plication: preclinical study of durability of serosa-to-serosa apposition. Surg Obes Relat Dis. 2011;7:8-14.
21. Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15:37-43.e1.
22. Lopez-nava G, Negi A, Bautista-castaño I, Rubio MA, Asokkumar R. Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs. laparoscopic sleeve gastrectomy (LSG). OBES SURG. 2020;30:2642-51.
23. Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013;78:530-5.
24. Banerjee S, Barth BA, Bhat YM, et al. Endoscopic closure devices. Gastrointest Endosc. 2012;76:244-51.
25. Stavropoulos SN, Modayil R, Friedel D. Current applications of endoscopic suturing. WJGE. 2015;7:777.
26. Kumar N, Abu Dayyeh BK, Lopez-nava Breviere G, et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg Endosc. 2018;32:2159-64.
27. Graus Morales J, Crespo Pérez L, Marques A, et al. Modified endoscopic gastroplasty for the treatment of obesity. Surg Endosc. 2018;32:3936-42.
28. Jain D, Bhandari BS, Arora A, Singhal S. Endoscopic sleeve gastroplasty - a new tool to manage obesity. Clin Endosc. 2017;50:552-61.
29. Espinet-coll E, Nebreda-durán J, Galvao-neto M, et al. Suture pattern does not influence outcomes of endoscopic sleeve gastroplasty in obese patients. Endosc Int Open. 2020;08:E1349-58.
30. Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943-53.
31. Alqahtani A, Al-darwish A, Mahmoud AE, Alqahtani YA, Elahmedi M. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019;89:1132-8.
32. Sartoretto A, Sui Z, Hill C, et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. OBES SURG. 2018;28:1812-21.
33. Lopez-nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. OBES SURG. 2017;27:2649-55.
34. de Miranda Neto AA, de Moura DTH, Ribeiro IB, et al. Efficacy and safety of endoscopic sleeve gastroplasty at mid term in the management of overweight and obese patients: a systematic review and meta-analysis. OBES SURG. 2020;30:1971-87.
35. Cheskin LJ, Hill C, Adam A, et al. Endoscopic sleeve gastroplasty versus high-intensity diet and lifestyle therapy: a case-matched study. Gastrointest Endosc. 2020;91:342-9.e1.
36. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. The Lancet. 2022;400:441-51.
37. Vilar-gomez E, Martinez-perez Y, Calzadilla-bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367-78.e5.
38. Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20:377-88.
39. Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol. 2017;15:504-10.
40. Mehta A, Hajifathalian K, Dawod QM, et al. 1106 - an analysis of leptin and insulin-glucose metabolism following endoscopic sleeve gastroplasty. Gastroenterology. 2019;156:S-236.
41. Nunes BCM, de Moura DTH, Kum AST, et al. Impact of endoscopic sleeve gastroplasty in non-alcoholic fatty liver disease: a systematic review and meta-analysis. OBES SURG. 2023;33:2917-26.
42. Hajifathalian K, Mehta A, Ang B, et al. Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. Gastrointest Endosc. 2021;93:1110-8.
43. Bhandari M, Kosta S, Reddy M, Mathur W, Neto MG, Bhandari M. Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India. J Minim Access Surg. 2023;19:101-6.
44. Sharaiha RZ, Hajifathalian K, Kumar R, et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin Gastroenterol Hepatol. 2021;19:1051-7.e2.
45. Jirapinyo P, Kumar N, Shaikh S, Trasolini R, Ryan M, Thompson C. Ten-year efficacy of endoscopic sleeve gastroplasty (ESG). Gastrointest Endosc. 2023;97:AB34-5.
46. Brunaldi VO, Galvao Neto M, Sharaiha RZ, et al. Endoscopic sleeve gastroplasty as an early tool against obesity: a multicenter international study on an overweight population. Gastrointest Endosc. 2024;99:371-6.
47. Alqahtani AR, Alqahtani O, Abdurabu H, et al. Endoscopic sleeve gastroplasty in those with a body mass index of 27-30. Am J Gastroenterol. 2023;118:1807-11.
48. Li R, Veltzke-schlieker W, Adler A, et al. Endoscopic sleeve gastroplasty (ESG) for high-risk patients, high body mass index (> 50 kg/m2) patients, and contraindication to abdominal surgery. OBES SURG. 2021;31:3400-9.
49. Alqahtani A, Elahmedi M, Alqahtani YA, Al-darwish A. Endoscopic sleeve gastroplasty in 109 consecutive children and adolescents with obesity: two-year outcomes of a new modality. Am J Gastroenterol. 2019;114:1857-62.
50. Hedjoudje A, Abu Dayyeh BK, Cheskin LJ, et al. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18:1043-53.e4.
51. Svagera Z, Machytka E, Machackova J, et al. Nutritional consequences of endoluminal gastroplasty in the treatment of morbidly obese patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165:258-63.
52. Beitner M, Hopkins G. Conversion of endoscopic sleeve gastroplasty to laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2020;16:590-1.
53. Alqahtani AR, Elahmedi M, Alqahtani YA, Al-darwish A. Laparoscopic sleeve gastrectomy after endoscopic sleeve gastroplasty: technical aspects and short-term outcomes. OBES SURG. 2019;29:3547-52.
54. Cheng Q, Tree K, Edye M, Devadas M. Reversal of endoscopic sleeve gastroplasty and conversion to sleeve gastrectomy - two case reports. Int J Surg Case Rep. 2020;68:180-4.
55. Sullivan S, Swain JM, Woodman G, et al. Randomized sham‐controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity. 2017;25:294-301.
56. Lopez-nava G, Asokkumar R, Turró Arau R, Neto MG, Dayyeh BA. Modified primary obesity surgery endoluminal (POSE-2) procedure for the treatment of obesity. VideoGIE. 2020;5:91-3.
57. Jirapinyo P, Thompson CC. Endoscopic gastric body plication for the treatment of obesity: technical success and safety of a novel technique (with video). Gastrointest Endosc. 2020;91:1388-94.
58. Lopez Nava G, Arau RT, Asokkumar R, et al. Prospective multicenter study of the primary obesity surgery endoluminal (POSE 2.0) procedure for treatment of obesity. Clin Gastroenterol Hepatol. 2023;21:81-9.e4.
59. Alkhatry M, Rapaka B, Maselli DB, et al. Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure. Endoscopy. 2023;55:1028-34.
60. Jirapinyo P, Zucker SD, Thompson CC. Regression of hepatic fibrosis after endoscopic gastric plication in nonalcoholic fatty liver disease. Am J Gastroenterol. 2023;118:983-90.
61. Singh S, Bazarbashi AN, Khan A, et al. Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysis. Surg Endosc. 2022;36:252-66.
62. Gkolfakis P, Van Ouytsel P, Mourabit Y, et al. Weight loss after endoscopic sleeve gastroplasty is independent of suture pattern: results from a randomized controlled trial. Endosc Int Open. 2022;10:E1245-53.
63. Huberty V, Machytka E, Boškoski I, Barea M, Costamagna G, Deviere J. Endoscopic gastric reduction with an endoluminal suturing device: a multicenter prospective trial with 1-year follow-up. Endoscopy. 2018;50:1156-62.
64. Huberty V, Boskoski I, Bove V, et al. Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial. Gut. 2021;70:1479-85.
65. Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425-38.e5.
66. Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: what happens 5 years thereafter? OBES SURG. 2012;22:896-903.
67. Fayad L, Cheskin LJ, Adam A, et al. Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. Endoscopy. 2019;51:532-9.
68. Singh S, de Moura DTH, Khan A, et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: a systematic review and meta-analysis. Obes Surg. 2020;30:3010-29.
69. Kozłowska-petriczko K, Pawlak KM, Wojciechowska K, et al. The efficacy comparison of endoscopic bariatric therapies: 6-month versus 12-month intragastric balloon versus endoscopic sleeve gastroplasty. OBES SURG. 2023;33:498-505.
70. Gudur AR, Geng CX, Podboy A. Early safety and efficacy comparison of endoscopic bariatric interventions. Surg Obes Relat Dis. 2023;19:1148-53.
71. Ard J, Fitch A, Fruh S, Herman L. Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Adv Ther. 2021;38:2821-39.
72. Wilding JP, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.
73. Rubino D, Abrahamsson N, Davies M, et al; STEP 4 Investigators. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325:1414.
74. Haseeb M, Chhatwal J, Xiao J, Jirapinyo P, Thompson CC. Semaglutide vs endoscopic sleeve gastroplasty for weight loss. JAMA Netw Open. 2024;7:e246221.
75. Benaiges D. Laparoscopic sleeve gastrectomy: more than a restrictive bariatric surgery procedure? WJG. 2015;21:11804-14.
76. Ifso Registry. The 8th IFSO Global Registry Report. Available from: https://www.ifso.com/ifso-registry.php. [Last accessed on 7 Jul 2025].
77. Novikov AA, Afaneh C, Saumoy M, et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare? J Gastrointest Surg. 2018;22:267-73.
78. Fayad L, Adam A, Schweitzer M, et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc. 2019;89:782-8.
79. Mohan BP, Asokkumar R, Khan SR, et al. Outcomes of endoscopic sleeve gastroplasty; how does it compare to laparoscopic sleeve gastrectomy? Endosc Int Open. 2020;08:E558-65.
80. Fiorillo C, Quero G, Vix M, et al. 6-month gastrointestinal quality of life (QoL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis. OBES SURG. 2020;30:1944-51.
81. Clapp B, Wynn M, Martyn C, Foster C, O’dell M, Tyroch A. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. 2018;14:741-7.
82. Nedelcu M, Noel P, Iannelli A, Gagner M. Revised sleeve gastrectomy (re-sleeve). Surg Obes Relat Dis. 2015;11:1282-8.
83. Andalib A, Alamri H, Almuhanna Y, Bouchard P, Demyttenaere S, Court O. Short-term outcomes of revisional surgery after sleeve gastrectomy: a comparative analysis of re-sleeve, Roux en-Y gastric bypass, duodenal switch (Roux en-Y and single-anastomosis). Surg Endosc. 2021;35:4644-52.
84. Yorke E, Sheppard C, Switzer NJ, et al. Revision of sleeve gastrectomy to Roux-en-Y gastric bypass: a Canadian experience. Am J Surg. 2017;213:970-4.
85. Alsabah S, Al Haddad E, Al-subaie S, et al. Short-term results of revisional single-anastomosis gastric bypass after sleeve gastrectomy for weight regain. OBES SURG. 2018;28:2197-202.
86. Biertho L, Thériault C, Bouvet L, et al. Second-stage duodenal switch for sleeve gastrectomy failure: a matched controlled trial. Surg Obes Relat Dis. 2018;14:1570-9.
87. Al-sabah S, Al Haddad E, Akrof S, Alenezi K, Al-subaie S. Midterm results of revisional bariatric surgery postsleeve gastrectomy: resleeve versus bypass. Surg Obes Relat Dis. 2020;16:1747-56.
88. Sharaiha RZ, Kedia P, Kumta N, Aronne LJ, Kahaleh M. Endoscopic sleeve plication for revision of sleeve gastrectomy. Gastrointest Endosc. 2015;81:1004.
89. de Moura DTH, Barrichello Jr S, de Moura EGH, et al. Endoscopic sleeve gastroplasty in the management of weight regain after sleeve gastrectomy. Endoscopy. 2020;52:202-10.
90. Maselli DB, Alqahtani AR, Abu Dayyeh BK, et al. Revisional endoscopic sleeve gastroplasty of laparoscopic sleeve gastrectomy: an international, multicenter study. Gastrointest Endosc. 2021;93:122-30.
91. Jirapinyo P, de Moura DT, Thompson CC. Sleeve in sleeve: endoscopic revision for weight regain after sleeve gastrectomy. VideoGIE. 2019;4:454-7.
92. Mahmoud T, Vargas EJ, Ghazi R, Abusaleh R, Storm AC, Abu Dayyeh BK. The osculating circles gastroplasty: a novel endoscopic submucosal resection enhanced endoluminal suturing for obesity. Gastroenterology. 2021;161:1806-8.e1.
93. Itani MI, Farha J, Sartoretto A, et al. Endoscopic sleeve gastroplasty with argon plasma coagulation: a novel technique. J of Digest Diseases. 2020;21:664-7.
94. Jirapinyo P, Thompson CC. Comparison of distal primary obesity surgery endolumenal techniques for the treatment of obesity (with videos). Gastrointest Endosc. 2022;96:479-86.
95. Khatry M, Abu Dayyeh BK. The primary obesity surgery endoluminal 2.0 enfolding technique (POSE 2.0et): modification to enhance efficiency and increase restriction. OBES SURG. 2023;33:1953-4.
96. Badurdeen D, Hoff AC, Hedjoudje A, et al. Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss. Gastrointest Endosc. 2021;93:1316-24.e1.
97. Thompson CC, Jirapinyo P, Shah R, Simsek C. Gastroplasty with endoscopic myotomy (GEM) for the treatment of obesity: preliminary efficacy and physiologic results. Gastroenterology. 2022;163:1173-5.
